LexaGene
Dr. Furtado has worked in the life sciences industry for over 30 years, with experience in discovery research, clinical diagnostic testing, product development and commercialization, M&A activity, fundraising and strategy. He currently serves as President and Founder of Biology for Global Good LLC and Chief Scientific Officer and Chief Regulatory Officer at Apton Biosystems. Additionally, as the former Vice President of R&D at Applied Biosystems, Dr. Furtado helped to build the company’s molecular diagnostics, genomic assays, human identification, food pathogen detection, animal health, pharmaceutical analytics, environmental testing and molecular medicine platforms, which generated over $500 million in revenue. Dr. Furtado has also served as a business development consultant to Bio-Rad, Advanced Cell Diagnostics, DxNow, RxFulcrum, Sample 6, Apton Biosystems and Vibrant Biosciences. He was Senior Director for Regulatory Affairs at Cepheid and appointed to the National Biodefense Science Board by the former Department of Health and Human Services Secretary Kathleen Sebelius.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
LexaGene
LexaGene is a molecular diagnostics company developing pathogens detection systems for: Veterinary Diagnostics, Human Clinical Diagnostics, Food safety, and open-access custom testing markets.